InsiderTrades

Form 4 for CNMD CONMED Corp

Accepted 2025-03-17 00:00:00 ET · period of report 2025-03-14 · accession 0001127602-25-009658 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-03-17 2025-03-14 CNMD SHAGORY PETER K EVP, STRAT, CORP DEVT M - OptEx $55.42 +4,500 8,213 +121% +$249.4K
D 2025-03-17 2025-03-14 CNMD SHAGORY PETER K EVP, STRAT, CORP DEVT F - Tax $58.83 -4,316 3,897 -53% -$253.9K
D 2025-03-17 2025-03-14 CNMD SHAGORY PETER K EVP, STRAT, CORP DEVT M - OptEx $0.00 -4,500 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-03-14 M A 4,500 $55.42 8,212.64 D — —
2 Common Common Stock 2025-03-14 F D 4,316 $58.83 3,896.64 D — —
3 Derivative SARs (Stock Appreciation Rights) 2025-03-14 M D 4,500 $0.00 0 D $55.42 · — to 2025-05-11 4,500 Common Stock (F1) The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.